Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

GentiBio
120 Kingston St., Ste. 810
Boston, MA 02111
https://www.gentibio.com/

GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.

Key Contact
Name
Adel Nada
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
08/05/20 $20,000,000 Seed Novartis Venture Funds
OrbiMed Advisors
RA Capital Management


Featured Reading